Therapy Areas: Diabetes
Diamyd Medical secures Eurasian patent for insulin-based antigen therapy in type 1 diabetes
11 September 2025 - Swedish clinical-stage pharmaceutical company Diamyd Medical (STO: DMYD-B) announced on Wednesday that the Eurasian Patent Office will grant a patent covering the use of insulin-ba...
Novo Nordisk to streamline operations and reinvest in diabetes and obesity growth
10 September 2025 - Danish pharmaceutical company Novo Nordisk A/S (CPH:NOVO-B) (NYSE:NVO) on Wednesday announced plans reduce its global workforce by approximately 9,000 of 78,400 positions, includin...
Sanofi secures China approval for Tzield as first disease-modifying therapy for stage 2 type 1 diabetes
10 September 2025 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) announced on Wednesday that China's National Medical Products Administration has approved Tzield (tepli...
NICE endorses AOTI's TWO2 therapy for diabetic foot ulcers
3 September 2025 - AOTI INC (AIM: AOTI), a medical technology group focused on durable wound healing and amputation prevention, announced that topical oxygen therapy has been included in updated Natio...
Advanz Pharma and Alvotech secure European approval for aflibercept biosimilar Mynzepli
21 August 2025 - Biotechnology company Alvotech SA (NASDAQ:ALVO) and pharmaceutical company Advanz Pharma Holdco Limited announced on Thursday that the European Commission has approved Mynzepli (AVT06...
OptiBiotix signs distribution deal with major weight management company
20 August 2025 - OptiBiotix Health plc (AIM: OPTI), a life sciences company specialising in microbiome-based health products, announced on Wednesday that it has signed a distribution agreement with a ...